Skip to content
Screener

InnovAge Holdings, Inc. INNV Noncontrolling interests in subsidiaries

Noncontrolling interests in subsidiaries at other companies

Humana logo
HumanaHUM
$64M+4.9%
UnitedHealth Group logo
UnitedHealth GroupUNH
$6.07B+5.6%
Astrana Health logo
Astrana HealthASTH
$14.93M+194%
Centene logo
CenteneCNC
$72M-16.3%
Privia Health Group, Inc. logo
Privia Health Group, Inc.PRVA
$55.74M+10.0%
Genworth Financial logo
Genworth FinancialGNW
$1.04B+4.6%

Other financials

Income statement

See full
Revenue$251.9M+15.5%
Operating income-$29.1M-186%
Net income-$29.5M-159%
EPS (diluted)-$0.22-175%

Balance sheet

See full
Cash & equivalents$95.5M+58.0%
Total debt$93.8M-11.0%
Total equity$229.0M-3.8%
Total assets$547.4M+2.0%

Cash flow

See full
Operating cash flow$18.1M-26.3%
CapEx$3.6M+24.3%
Free cash flow$14.5M-33.1%

Valuation

See full
Market cap$1.52B+248%
Enterprise value$1.52B+220%
P/S1.6×+1.1×

Profitability

See full
Operating margin-1%-0.4pp
Net margin-1.2%-0.5pp
FCF margin4.5%+2.6pp

Returns & leverage

See full
Return on equity-5%-1.8pp
Debt / equity0.4×0.0×
Current ratio+0.3×

Where this comes from

Reported directly by InnovAge Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:MinorityInterest.

The source filing: InnovAge Holdings, Inc.’s 10-Q, filed May 8, 2026.

Filed
May 7, 2026, 8:00 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001834376-26-000022
Line itemMarch 31,2026June 30,2025
Common stock, $0.001 par value; 500,000,000 authorized as of March 31, 2026 and June 30, 2025; 137,174,126 issued and 135,711,147 outstanding as of March 31, 2026 and 136,903,271 issued and 135,440,292 outstanding as of June 30, 2025137137
Treasury stock at cost, 1,462,979 shares as of March 31, 2026 and June 30, 2025(7,500)(7,500)
Additional paid-in capital348,264343,378
Retained deficit(111,871)(101,047)
Total InnovAge Holding Corp.229,030234,968
Noncontrolling interests3,7492,930
Total stockholders’ equity232,779237,898
Total liabilities and stockholders’ equity$547,394$526,851

Item 1. Financial Statements (Unaudited)

FAQ

What is InnovAge Holdings, Inc.'s noncontrolling interests in subsidiaries?
InnovAge Holdings, Inc. (INNV) reported noncontrolling interests in subsidiaries of $3.75M in Q1 2026.
How has InnovAge Holdings, Inc.'s noncontrolling interests in subsidiaries changed year-over-year?
InnovAge Holdings, Inc.'s noncontrolling interests in subsidiaries decreased by 50.9% year-over-year, from $7.64M to $3.75M.
What is the long-term trend for InnovAge Holdings, Inc.'s noncontrolling interests in subsidiaries?
Over 4 years (2021 to 2025), InnovAge Holdings, Inc.'s noncontrolling interests in subsidiaries has grown at a -17.8% compound annual growth rate (CAGR), from $6.42M to $2.93M.
What does noncontrolling interests in subsidiaries mean?
This represents the portion of a subsidiary's net assets that is owned by outside shareholders rather than the parent company. It is reported within equity to show the total value of the subsidiary's assets and liabilities that are not attributable to the parent. It reflects the non-controlling stake in consolidated entities.

Ask your AI about InnovAge Holdings, Inc.'s noncontrolling interests in subsidiaries.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude